Published in Cancer Weekly, April 2nd, 2002
These solid tumors include prostate cancer, lung cancer, breast cancer, and other solid tumor types. In prostate cancer, patients should have progressed after treatment with at least one hormonal therapy.
The trials that led to the approval of Zometa mark the first time any bisphosphonate has demonstrated efficacy in treating bone complications in patients with prostate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.